Multi-Dimensional Gastrointestinal Symptom Severity Index: Validation of a Brief GI Symptom Assessment Tool

被引:21
|
作者
Crowell, Michael D. [1 ]
Umar, Sarah B. [1 ]
Lacy, Brian E. [2 ]
Jones, Michael P. [3 ]
DiBaise, John K. [1 ]
Talley, Nicholas J. [4 ]
机构
[1] Mayo Clin Arizona, Div Gastroenterol & Hepatol, Scottsdale, AZ 85259 USA
[2] Dartmouth Hitchcock Med Ctr, Gastroenterol & Hepatol, Lebanon, NH 03766 USA
[3] Henrico Doctors Hosp, Gastroenterol, Richmond, VA USA
[4] Univ Newcastle, Newcastle, NSW 2300, Australia
关键词
Gastrointestinal Symptoms Severity Index; Psychometrics; Gastrointestinal symptoms; Urogynecologic symptoms; Pelvic symptoms; IRRITABLE-BOWEL-SYNDROME; FUNCTIONAL DYSPEPSIA; RISK-FACTORS; COMMUNITY; BURDEN; GASTROPARESIS; CONSTIPATION; PREVALENCE; DISORDERS; SUBGROUPS;
D O I
10.1007/s10620-015-3647-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Few instruments have been developed and validated for the evaluation of multi-dimensional GI symptoms. The Gastrointestinal Symptoms Severity Index (GISSI), a multi-dimensional, self-report instrument, was designed as a brief measure of the frequency, severity, and bothersomeness of individual GI and pelvic floor/urogynecologic symptoms. Aim To report the psychometric properties of the GISSI subscales, including factorial structure, validity, and internal consistency. Methods The GISSI included 32 items that assessed upper and lower GI symptoms and seven items related to pelvic floor/urogynecologic symptoms. A total of 934 patients presenting for upper and lower GI complaints completed the questionnaire between January 2013 and December 2013. The sample was randomly split into derivation (n=466) and validation datasets (n=468). A non-patient sample of 200 was collected separately. Results Exploratory factor analysis supported a six-factor model for the derivation sample that accounted for 69.3 % of the total variance. The six GI symptom clusters were labeled as constipation/difficult defecation (five items), abdominal pain/discomfort (four items), dyspepsia (four items), diarrhea/anal incontinence (four items), GERD/chest symptoms (four items), and nausea/vomiting (two items). Inclusion of additional items related to female pelvic floor/urogynecologic symptoms resulted in a separate factor. Confirmatory factor analysis of the validation dataset supported the a priori hypothesized six-factor measurement model (X-2(428)=1462.98; P<0.001; GFI=.88; RMSEA=.051). Conclusion The GISSI demonstrated good to excellent psychometric properties and provided multi-dimensional scaling of prominent GI symptom clusters. Further validation may provide an efficient, valid, and reliable measure of patient-reported clinical outcomes.
引用
收藏
页码:2270 / 2279
页数:10
相关论文
共 50 条
  • [21] Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsia
    Adam, B
    Liebregts, T
    Saadat-Gilani, K
    Vinson, B
    Holtmann, G
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (04) : 357 - 363
  • [22] Assessment of symptom frequency and severity in hemodialysis patients using the dialysis symptom index (DSI); A single center experience
    Tomar, Ozdem Kavraz
    Akagun, Tulin
    Usta, Murat
    Baylan, Suleyman
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2024, 15 (10): : 708 - 712
  • [23] A NEW BRIEF LOWER URINARY TRACT SYMPTOMS CLINICAL ASSESSMENT TOOL FOR WOMEN AND MEN: THE LURN SYMPTOM INDEX
    Cella, David
    Smith, Abigail R.
    Griffith, James W.
    Flynn, Kathryn E.
    Gillespie, Brenda W.
    Bradley, Catherine S.
    Helmuth, Margaret E.
    Talaty, Pooja
    Merion, Robert M.
    Weinfurt, Kevin P.
    Kirkali, Ziya
    JOURNAL OF UROLOGY, 2019, 201 (04): : E568 - E568
  • [24] Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders
    Rentz, AM
    Kahrilas, P
    Stanghellini, V
    Tack, J
    Talley, NJ
    de la Loge, C
    Trudeau, E
    Dubois, D
    Revicki, DA
    QUALITY OF LIFE RESEARCH, 2004, 13 (10) : 1737 - 1749
  • [25] Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders
    A.M. Rentz
    P. Kahrilas
    V. Stanghellini
    J. Tack
    N.J. Talley
    C. De la loge
    E. Trudeau
    D. Dubois
    D.A. Revicki
    Quality of Life Research, 2004, 13 : 1737 - 1749
  • [26] Validation of the 3D SYM VEIN Symptom Assessment Tool
    Kakkos, Stavros K.
    Papageorgopoulou, Chrysanthi P.
    Nikolakopoulos, Konstantinos M.
    Kalogeropoulou, Christina
    Tsolakis, Ioannis A.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2020, 60 (04) : 587 - 593
  • [27] Validation of the Gastrointestinal Pain Pointer (GIPP) as a Measure of Symptom Severity in Persons With Abdominal Pain
    Henderson, Wendy A.
    Martino, Angela C.
    Taylor, Tara J.
    Shankar, Ravi
    Chen, Kong
    Kim, Kevin H.
    Berger, Ann M.
    Zuccolotto, Anthony P.
    Heitkemper, Margaret
    GASTROENTEROLOGY, 2010, 138 (05) : S478 - S478
  • [28] Validation of the PCL-5 Symptom Severity Scale Embedded Symptom Validity Index in a Cross-Cultural Forensic Sample
    Snodgrass, Makenna
    Schroeder, Ryan W.
    Spector, Jack
    Bieu, Rachel
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2024, 39 (07) : 1235 - 1235
  • [29] SymptoMScreen: A Tool for Rapid Assessment of Symptom Severity in MS Across Multiple Domains
    Green, R.
    Kalina, J.
    Ford, R.
    Pandey, K.
    Kister, I.
    APPLIED NEUROPSYCHOLOGY-ADULT, 2017, 24 (02) : 183 - 189
  • [30] Extended Validation of the IgG4-Related Disease Symptom Severity Index (SSI)
    Jha, Isha
    McMahon, Grace
    Katz, Guy
    Srivatsan, Shruthi
    Bolden, Caleb
    Fernandes, Ana
    Perugino, Cory
    Stone, John
    Wallace, Zachary
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3415 - 3417